Ultrasound Measure of the Thickness of the Lower Segment in Women Having a History of Caesarian

August 29, 2025 updated by: Assistance Publique - Hôpitaux de Paris

Evaluation of the Efficiency of the Ultrasound Measure of the Thickness of the Lower Segment Associated With a Rule of Decision to Reduce the Foetal and Maternal Morbidity and Mortality in the Care of the Deliveries of the Women Having a History of Caesarian: a Pragmatic Randomized Trial : Lustrial

The rate of caesarians dramatically increased for 15 years. The main indication of caesarian became the iterative caesarian of principle because of a history of caesarian. Any attempt of reduction of the rate of caesarians should thus focus on the indications of iterative principal caesarean. Nevertheless, the main reason usually evoked to justify a reduction of the attempts of low way after caesarian is the concern generated by the risk of uterine break during the trial of labor. Yet, there is no reliable method to predict this risk of uterine break. A way of interesting research consists in estimating the potential profits of the echography of the scar lower segment. Indeed, the echography can be useful to determine the specific risk of uterine break of a patient by measuring the thickness of the lower segment of the womb.

The strong negative predictive value of the echography of the lower segment on the risk of uterine break should encourage the women encircled to accept a trial of labor. That is why, this examination associated with a rule of decision could help to decrease the rate of iterative elective caesarians and especially to decrease the mortality and the foetal and maternal morbidity connected to the trial of labor among the patients having a history of caesarian.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

"Lower Uterine Segment Trial (LUSTrial)" Evaluation of the efficiency of the ultrasound measure of the thickness of the lower segment associated with a rule of decision to reduce the foetal and maternal morbidity and mortality in the coverage of the deliveries of the women having a history of caesarian: a pragmatic randomized trial

Aim Evaluation of the efficiency of the ultrasound measure of the thickness of the lower segment associated with a rule of decision to reduce the foetal and maternal morbidity and mortality in the coverage of the deliveries of the women having a history of caesarian Methodology Randomized trial, multicentric, open, in two parallel arms.

Evaluated treatments:

Between 36+0 and 38+6 weeks of amenorrhea, the patients will be invited to participate in the study. After agreement, the patients respecting the criteria of inclusion and not inclusion will be randomized in two groups:

GROUP A (experimental group) : The ultra sound measure of the thickness of the lower segment will be realized in a way standardized by expert sonographers. The patient will be informed that in case of measure:

  • superior at the threshold of 3.5 mm, her will be considered " a low risk " by complications and will be encouraged to try a event of the work
  • subordinate or equal at the threshold of 3.5 mm, her will be considered " at risk " by complications and will be encouraged to give birth by iterative elective caesarian.

GROUP B (control group) : The ultra sound measure of the lower segment will not be realized. The mode of delivery will be decided according to the current clinical practice.

Study Type

Interventional

Enrollment (Actual)

2955

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Poissy, France
        • CHI Poissy Saint Germain

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • age ≥ 18 years
  • unique pregnancy
  • gestational age between 36 SA and 38SA +6 days
  • cephalic presentation
  • lower uterine segment section's history
  • sign consent

Exclusion Criteria:

  • age < 18 years
  • history of longitudinal incision's caesarean
  • iterative caesarean indication
  • multiple pregnancy
  • placenta praevia
  • patient refuse trial of labor
  • absent consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Lower Uterine Segment Ultrasound
Measure of Uterine Segment by Ultrasound
Measure of Uterine Segment by Ultrasound
No Intervention: control
no measure of Uterine Segment Ultrasound

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Composite criterion including maternal and neonatal parameters
Time Frame: at 3 days post partum
rupture uterine, uterine dehiscence, hysterectomy, deep venous thromboembolic complications, transfusion, endometritis, maternal mortality, foetal mortality antepartum, intrapartum foetal mortality, ischemic hypoxic encephalopathy, neonatal mortality
at 3 days post partum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Uterine rupture
Time Frame: at 3 days post partum
at 3 days post partum
Uterine dehiscence
Time Frame: at 3 days post partum
Maternal morbidity
at 3 days post partum
Antepartum and intrapartum mortality
Time Frame: 3 days post partum
Foetal mortality
3 days post partum
Hypoxic-ischemic encephalopathy
Time Frame: at 3 days post partum
New born morbidity
at 3 days post partum
Thromboembolic complications
Time Frame: at 3 days post partum
Maternal morbidity
at 3 days post partum
Hysterectomy
Time Frame: at 3 days post partum
Maternal morbidity
at 3 days post partum
Transfusion
Time Frame: at 3 days post partum
Maternal morbidity
at 3 days post partum
Endometritis
Time Frame: at 3 days post partum
Maternal morbidity
at 3 days post partum
Rate of elective caesarean sections and of caesarean sections during labor
Time Frame: at 1 day post partum
at 1 day post partum
Perineal tears of the 3rd and 4th degree
Time Frame: at 1 day post partum
at 1 day post partum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Patrick Rozenberg, MD, PhD, Chi Poissy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 11, 2013

Primary Completion (Actual)

May 11, 2018

Study Completion (Actual)

January 22, 2019

Study Registration Dates

First Submitted

August 2, 2013

First Submitted That Met QC Criteria

August 2, 2013

First Posted (Estimated)

August 5, 2013

Study Record Updates

Last Update Posted (Estimated)

September 5, 2025

Last Update Submitted That Met QC Criteria

August 29, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labor

Clinical Trials on Ultrasound

Subscribe